Group One Trading’s Repros Therapeutics Inc. RPRX Stock Holding History

Group One Trading’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-8,200	Closed	-$5K	–	5766
2017 Q4	$5K	Sell	8,200 -52,000	-86%	-$26.3K	﹤0.01%	4584
2017 Q3	$19K	Sell	60,200 -83,300	-58%	-$29.2K	﹤0.01%	4101
2017 Q2	$66K	Sell	143,500 -17,400	-11%	-$12.6K	﹤0.01%	3360
2017 Q1	$193K	Sell	160,900 -74,400	-32%	-$93K	﹤0.01%	2549
2016 Q4	$311K	Buy	235,300 +57,800	+33%	+$101K	﹤0.01%	2103
2016 Q3	$371K	Sell	177,500 -8,500	-5%	-$16.8K	﹤0.01%	2036
2016 Q2	$299K	Buy	186,000 +152,700	+459%	+$293K	﹤0.01%	2130
2016 Q1	$32K	Buy	+33,300	New	+$32.5K	﹤0.01%	3510

Group One Trading's RPRX Position: Q1 2018 in Review

Group One Trading sold out of Repros Therapeutics Inc. (RPRX) in Q1 2018, closing a stake of 24,735 shares — an estimated $16K sold.

Group One Trading first reported a position in RPRX in Q1 2016 and held it in 2 quarters. The position peaked at $16K in Q4 2017. 1 fund tracked by Wall St. Rank holds RPRX as of Q1 2018.

Group One Trading reported no remaining Repros Therapeutics Inc. position as of Q1 2018 after selling out during the quarter.
Group One Trading sold 24,735 Repros Therapeutics Inc. shares in Q1 2018, an estimated $16K.
Group One Trading first reported a position in Repros Therapeutics Inc. in Q1 2016 and held it in 2 quarters.
Group One Trading's Repros Therapeutics Inc. position peaked at $16K in Q4 2017.
1 fund tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2018.

Based on Group One Trading's 13F filing for Q1 2018, filed 11 May 2018.